# Lithium and Acetate for Canavan Disease

> **NCT00657748** · PHASE2 · WITHDRAWN · sponsor: **Assistance Publique - Hôpitaux de Paris**

## Conditions studied

- Canavan Disease
- Infantile
- Deficiency Disease
- Aspartoacylase
- Leukodystrophy, Spongiform

## Interventions

- **DRUG:** Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)

## Key facts

- **NCT ID:** NCT00657748
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657748, "Lithium and Acetate for Canavan Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00657748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*